EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors associated with interval colorectal cancer after negative FIT : Results of two screening rounds in the Dutch FIT ‐based CRC screening program

Emilie C H Breekveldt iD, Esther Toes-Zoutendijk iD, Hilliene J van de Schootbrugge-Vandermeer iD, Lucie de Jonge iD, Arthur I Kooyker iD, Manon C W Spaander iD, Anneke J van Vuuren iD, Folkert J van Kemenade iD, Christian Ramakers iD, Evelien Dekker iD, Iris D Nagtegaal iD, Monique E van Leerdam iD und 1 weitere

International Journal of Cancer · 15.04.2023 · 152 (8) · 1536-1546

DOI: 10.1002/ijc.34373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2022-12. Verfasst von Emilie C H Breekveldt und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Early Detection of Cancer, Colorectal Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rijksinstituut voor Volksgezondheid en Milieu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interval colorectal cancer (CRC) rate after negative fecal immunochemical testing (FIT) is an important quality indicator of CRC screening programs. We analyzed the outcomes of two rounds of the FIT‐based CRC screening program in the Netherlands, using data from individuals who participated in FIT‐screening from 2014 to 2017. Data of individuals with one prior negative FIT (first round) or two prior negative FITs (first and second round) were included. Outcomes included the incidence of interval CRC in FIT‐negative participants (40‐46.9 μg/g) had a higher probability of detecting an interval CRC (OR 16.9; 95%CI: 14.0‐20.4) than had participants with unmeasurable f‐Hb (0‐2.6 μg/g). After two screening rounds, the odds ratio for interval CRC was 12.0 (95%CI: 7.8‐17.6) for participants with f‐Hb just below the cut‐off compared with participants with unmeasurable f‐Hb. After both screening rounds, the Dutch CRC screening program had a low incidence of interval CRC and an associated high FIT‐sensitivity. Our findings suggest there is a potential for further optimizing CRC screening programs with the use of risk‐stratified CRC screening based on prior f‐Hb.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerColorectal NeoplasmsHumansHemoglobinsOccult BloodFecesMass ScreeningColonoscopy

Stichwörter der Autor:innen

colorectal cancercolorectal cancer screeningfecal immunochemical testing

Substanzen

Hemoglobins

Autor:innen und Institutionen

  • Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Department of Gastroenterology and Hepatology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Department of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers-Academic Medical Center, Amsterdam, The Netherlands.

ORCID-Profile: Emilie C H Breekveldt, Esther Toes-Zoutendijk, Hilliene J van de Schootbrugge-Vandermeer, Lucie de Jonge, Arthur I Kooyker, Manon C W Spaander, Anneke J van Vuuren, Folkert J van Kemenade, Christian Ramakers, Evelien Dekker, Iris D Nagtegaal, Monique E van Leerdam, Iris Lansdorp-Vogelaar

Förderung

  • Rijksinstituut voor Volksgezondheid en Milieu

Zitieren

APA

Breekveldt, E. C. H., Toes-Zoutendijk, E., van de Schootbrugge-Vandermeer, H. J., de Jonge, L., Kooyker, A. I., Spaander, M. C. W., van Vuuren, A. J., van Kemenade, F. J., Ramakers, C., Dekker, E., Nagtegaal, I. D., van Leerdam, M. E., & Lansdorp-Vogelaar, I. (2023). Factors associated with interval colorectal cancer after negative FIT : Results of two screening rounds in the Dutch FIT ‐based CRC screening program. International Journal of Cancer, 152(8), 1536-1546. https://doi.org/10.1002/ijc.34373

Vancouver

Breekveldt ECH, Toes-Zoutendijk E, van de Schootbrugge-Vandermeer HJ, de Jonge L, Kooyker AI, Spaander MCW, et al. Factors associated with interval colorectal cancer after negative FIT : Results of two screening rounds in the Dutch FIT ‐based CRC screening program. International Journal of Cancer. 2023;152(8):1536-1546. doi:10.1002/ijc.34373

BibTeX
@article{Breekveldt2023,
  author = {Breekveldt, Emilie C H and Toes-Zoutendijk, Esther and van de Schootbrugge-Vandermeer, Hilliene J and de Jonge, Lucie and Kooyker, Arthur I and Spaander, Manon C W and van Vuuren, Anneke J and van Kemenade, Folkert J and Ramakers, Christian and Dekker, Evelien and Nagtegaal, Iris D and van Leerdam, Monique E and Lansdorp-Vogelaar, Iris},
  title = {Factors associated with interval colorectal cancer after negative FIT : Results of two screening rounds in the Dutch FIT ‐based CRC screening program},
  journal = {International Journal of Cancer},
  year = {2023},
  volume = {152},
  number = {8},
  pages = {1536--1546},
  doi = {10.1002/ijc.34373}
}
Kostenlos starten →